Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1976-12-1
|
pubmed:abstractText |
The broncholytic effect and plasma concentrations of theophylline in 10 asthmatic patients were studied for 8 hours after a single dose of 600 mg choline theophyllinate in press-coated 200 mg tablets. Therapeutic concentrations of theophylline were rapidly achieved and the plasma peak averaged 10.4 mug/ml after 2 hours. The broncholytic effect was closely related to the plasma level of theophylline. The largest change was in FEV1, which was significantly increased 1 to 6 hours after the dose. No patient complained of adverse effects. A theophylline concentration of 7 mug/ml plasma was adequate for a broncholytic effect, but a higher level was required for a maximal response. The results provide a basis for further studies to establish a dosage schedule suitable for prolonged therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0031-6970
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-8
|
pubmed:dateRevised |
2009-10-27
|
pubmed:meshHeading |
pubmed-meshheading:1233207-Adult,
pubmed-meshheading:1233207-Asthma,
pubmed-meshheading:1233207-Bronchi,
pubmed-meshheading:1233207-Choline,
pubmed-meshheading:1233207-Female,
pubmed-meshheading:1233207-Forced Expiratory Volume,
pubmed-meshheading:1233207-Humans,
pubmed-meshheading:1233207-Isoproterenol,
pubmed-meshheading:1233207-Kinetics,
pubmed-meshheading:1233207-Male,
pubmed-meshheading:1233207-Middle Aged,
pubmed-meshheading:1233207-Peak Expiratory Flow Rate,
pubmed-meshheading:1233207-Tablets,
pubmed-meshheading:1233207-Theophylline,
pubmed-meshheading:1233207-Vital Capacity
|
pubmed:year |
1975
|
pubmed:articleTitle |
Plasma level and broncholytic effect of choline theophyllinate after a single dose of a press-coated tablet formulation.
|
pubmed:publicationType |
Journal Article
|